|1.||McCabe, Michael T: 1 article (01/2009)|
|2.||Vertino, Paula M: 1 article (01/2009)|
|3.||Lee, Eva K: 1 article (01/2009)|
01/01/2009 - "In addition to many non-PRC2 targets, SUPER-PatMAn identified a subset of PRC2 targets that were more likely to be hypermethylated in cancer. "
01/01/2009 - "Although trained on data from a cell culture model of de novo methylation involving the overexpression of DNMT1, PatMAn accurately predicted CpG islands at increased risk of hypermethylation in cancer cell lines and primary tumors. "
01/01/2009 - "Here, we report on the genome-wide application and direct testing of PatMAn in cancer. "